0001428336-20-000014.txt : 20200417 0001428336-20-000014.hdr.sgml : 20200417 20200416174029 ACCESSION NUMBER: 0001428336-20-000014 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20200413 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20200417 DATE AS OF CHANGE: 20200416 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHEQUITY, INC. CENTRAL INDEX KEY: 0001428336 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36568 FILM NUMBER: 20797271 BUSINESS ADDRESS: STREET 1: 15 WEST SCENIC POINTE DRIVE STREET 2: SUITE 100 CITY: DRAPER STATE: UT ZIP: 84020 BUSINESS PHONE: 801-727-1000 MAIL ADDRESS: STREET 1: 15 WEST SCENIC POINTE DRIVE STREET 2: SUITE 100 CITY: DRAPER STATE: UT ZIP: 84020 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHEQUITY INC DATE OF NAME CHANGE: 20080227 8-K 1 hqy-20200413.htm 8-K hqy-20200413
0001428336false00014283362020-04-132020-04-13

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

April 13, 2020

HEALTHEQUITY, INC.


Delaware
001-36568
52-2383166
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)
(I.R.S. Employer
Identification Number)

15 West Scenic Pointe Drive
Suite 100
Draper, Utah 84020
(801) 727-1000

(Address, including Zip Code, and Telephone Number, including Area Code, of Registrant’s Principal Executive Offices)

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.0001 per shareHQYThe NASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). 
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐






Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

The Board of Directors (the “Board”) of HealthEquity, Inc. (the “Company”), upon recommendation by the Nominating and Corporate Governance Committee of the Board, has nominated each of the current directors for election, and each has decided to stand for re-election at the 2020 Annual Meeting of Stockholders, with the exception of Frank T. Medici, who on April 13, 2020 notified the Board of his decision not to stand for re-election at the 2020 Annual Meeting of Stockholders. The Board has reduced the size of the Board to nine members effective immediately following the 2020 Annual Meeting of Stockholders. Mr. Medici will continue to serve as a director until the Company’s 2020 Annual Meeting of Stockholders to be held on June 25, 2020.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

HEALTHEQUITY, INC.
Date: April 16, 2020By:/s/ Darcy Mott
Name:Darcy Mott
Title:Executive Vice President and Chief Financial Officer


 EX-101.SCH 2 hqy-20200413.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 3 hqy-20200413_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 4 hqy-20200413_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 hqy-20200413_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name Entity Address, Address Line Two Entity Address, Address Line Two City Area Code City Area Code Cover page. Cover [Abstract] Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Local Phone Number Local Phone Number Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code Trading Symbol Trading Symbol Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name EX-101.PRE 6 hqy-20200413_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( Z-D% ?(\\#P !," + 7W)E;',O+G)E;'.MDD^+ MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F' M.>RGGD7E2B.5^S3%":4A+,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C M-R."?S]PN -02P,$% @ #HV04"?HAPZ" L0 ! !D;V-0&UL38Y-"\(P$$3_2NG=;BGH06) L$?!D_>0;FP@R8;-"OGYIH(? MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/ M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+"" MWTG] E!+ P04 " .C9!0'V5! NX K @ $0 &1O8U!R;W!S+V-O M&ULS9+!:L,P#(9?9?B>R$Y#!R;-96.G%@8K;.QF;+4UBV-C:R1]^SE9 MFS*V!]C1TN]/GT"-#E+[B,_1!XQD,=V-KNN3U&'#3D1! B1]0J=2F1-];AY\ M=(KR,QXA*/VAC@@5YVMP2,HH4C !B[ 06=L8+75$13Y>\$8O^/ 9NQEF-&"' M#GM*($H!K)TFAO/8-7 #3##"Z-)W RDLX!-^PZ^77U\+A_8FW%*U[PNA#KO;B7-9>B?I]< M?_C=A)TW]F#_L?%5L&W@UUVT7U!+ P04 " .C9!0F5R<(Q & "<)P M$P 'AL+W1H96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03 M621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS M[BYBZ(:(E/)X8-DOV]:[MR_>X%#BVR]*+41B1%G\@MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C( MWXV(]ZMOFCU7H5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU M+,76>)7 \:V@S&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=* MY \FIS_I,C0'HYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_ MT=HWPJOX@L Y?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=R MSTS0LS0[=R M2^JVE+ZU)CA*]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZ MG=PZ.)Z8D;D*TU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCR MHB'NH8:8S\-#AWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)2 M56 Q6\8#*Y"B?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYE ML<%5'<]56_*POFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7G MFYRN>B)V^I=WP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5 M' 86%S+D4.Z2D 83 >LX=SFWJXPD6L_UC6'ODR MWSEPVSK> U[F$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\ MU*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHS MU8NL.8T*;T'50.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\! M4$L#!!0 ( Z-D%#JK380J@( /X+ 8 >&PO=V]R:W-H965T&UL=5;MCILP$'P5Q ,ZLO5N(5L6W7LPG]R\ZO;*SO+IBJGNN&MKF6;*'[>I)_(>D=GCN 1 MKS7O]<,X<4SESI^Y$*Z2W<>?L6@Z:3KBX_BC M^A=_>'N8 ]/\68K?]?F6';2LD^ M4+T J47GEX^T(M@?Q!1X@(E*E "^BP0@(@Y+C!#!6: O@@$(&*)"\Q1 M@3F@KP(!B" YKK! %1:03P()!!+Q>8E*+"$_-!J!1)Q>H1(KR ^M1B 1KTF. MQRF'%4*[,4S$.P)#'5!0Q4$$U/!DT]@K@OPCB&8B K%LT]AKHLR4,$PLX@*GGT*&ULA57;;MI $'U.OV*$^M!*@"\0@BJ"9 %I M4%+BU(ZBM.K#8B_VJMY=9W=-X.\[AC25O#A]\F7.GIES9L:>:&U@QPNA+SNY M,>47Q]%)3CG1?5E2@9&-5)P8?%29HTM%2:IS2@TO'-]U1PXG3'2@$NRYHC-9 M"7/9&0X[TXEFTXF9SN26*@A)1B>.F4Z<^NTQ$I2J#]Z@"[[KN\W@\=C/8*V- M(HGYU8S/95)Q*@S$^])B'O=N6O$A54RFL! IS(EI+>K#V=FILA;",+.'*U90 M6%5\3543X;I>;S Z'XU;CGZG&:LU82DKPJW\UXO@-KY>W#\LXZS?@O/ M4B12E5(1PZ3H0F10#$@%APZH/5Y3BWR^:"&+R0Z6*=K#-BPY,+:H._=[_F \ M\$:C%J8@3175NOOW!FZ9H' GK%J\ZCDEHG$JOTA_A]%*+4A!?Q@ MYC8>GMN/ @)MX^HCK-5_=R@1SA+D4;7-[X5_TT#(KU:-BQE"!B3C''3]. MAVZB-J305AV1+%C"#!,9?$.;%"-%$Q(JVDN0F:)UQW6F(L7%O]ML[!(M\%+K M"L'OG8F9P565&_#\3^O/$-&D0D%[^W/#.0Z]-C+YW862*-B2HJ+PT>VC)Q[@ M*(#.B;(TQHJDM&ULU55;B]4P$/XK(3_ G';9!:4MZ,*"H+*PY\'7M)VV@=Q,I\=V?[U)T]O1 M!_'@@[XT,]],OOERF33K<9+PT@$@&974?4X[1/N.L;[J0/'^C;&@?:0Q3G'T MKFM9;QWPN@^3E&3IZ?3 %!>:%ID>U)/"GE1FT)C3$V5%UAB](WN]*Z32=.7D&?PF1Q3Y/UBML'9^2])[N$^;!%RF- MJ\%M91*Z0D4FH0ERG&B[,**Q+ 01C?)&+7AK-)\UK#,6P]-6(.5+.,*OS17W MV)"8\[$.QT""BM7TJU[,>%S1"?Q'MLA]H+V_B998<3'X8?"KT;/_;3 (SPX: M,<[^V&SU/3NW5D[OI6BU@KB6WQ9,;BQ89'RM0SKCQ*OG"S>E\@ X2B[@4%1' MY+OC]@PCKK=I;&[5G/Z'FO_V/K>@P7%Y%.VO_K^\RW^BF"W=>&%S.F7\/#*JS[9^]33(R_] W[%[^?6T/!!XG-8\1S,Z6Y_ M"B]-\K!EG3>*G.[V9ZC%H-[.!?>_1/$#4$L#!!0 ( Z-D% M;:5H.@$ M "<" / >&PO=V]R:V)O;VLN>&ULC5'!;L(P#/V5*A^P%K0A#5$NH&U( MTX;&Q#VT+K5(XLIQ8>/KEP1UL-M.CI_MY^>7V8GXL",Z9%_6.%^J5J2;YKFO M6K#:WU$'+E0:8JLEI+S/?<>@:]\"B#7YN"@FN=7HU'PV<*TYOTU(H!(D%\ ( M;!%._EJ/::9#PQ$^]:Y4A_0[4LU4EF#[&43=Z=.BPXM MGJ%.F6_I]$*,9W*BS:9B,B9-Q4(:"AO\+[(%%JS^-(K>?>B@M523(A >T>,. M##%QRO^QD9H&*UA2U5MP94Y;:%4 M"SH"9VN]AR@[;%G5EQ,DF'/5E?$40X%7]2AI'(35T*"#^BUP^8"'>ZLU9S$D MGO']P^@Q^-H;LPC8NWLEG?@CQ_!'\Q]02P,$% @ #HV04/_ )@B] MA0( !H !X;"]? *A0V$LZ&8O:3RKC>LG^Z&JPLFAEC1"'X17FP?+)K=$U'AZS@>S'G10R/'1Y?,5'W])=9SUZ",*V'O\E$_37 ZM=E7U!+ M P04 " .C9!0"X_8 R$! !7! $P %M#;VYT96YT7U1Y<&5S72YX M;6RU5$U/PS ,_2M3KVC-X, !;;L 5Y@$?R D;ALU7[*]T?U[W&Y#8BIB:-LE MB?/L]UX2*_/W;0::=,%'6A0-BVD1[1#K=$Y8(?LBAQF6Z MD81B\MP)"\G>HA"4"G6"PG%A'TO=ZP80G85_64M5Y0S89-9!2DK*"-I2 \#! ME]1H!/O&Z&*]][O2R"\Z"+'JO/J14%[/!V\]C!L8D$LJL[0%C$D-P&Z\/4OP MT TF(4PS"HKL1HXGEE:"DNH3+WE$Z%O'@CU)7*BO]["?"=MA/7;AWR"I83KO MUO]H=)G+H%W\S&PO=&AE;64O=&AE;64Q+GAM;%!+ M 0(4 Q0 ( Z-D%#JK380J@( /X+ 8 " ?<( !X M;"]W;W)K&PO&PO&PO7W)E;',O=V]R:V)O M;VLN>&UL+G)E;'-02P$"% ,4 " .C9!0"X_8 R$! !7! $P M @ '-$@ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 "@ * ( " ( ?% ! end XML 8 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 9 0001428336-20-000014-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001428336-20-000014-xbrl.zip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etaLinks.json IDEA: XBRL DOCUMENT { "instance": { "hqy-20200413.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "hqy-20200413_cal.xml" ] }, "definitionLink": { "local": [ "hqy-20200413_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "hqy-20200413.htm" ] }, "labelLink": { "local": [ "hqy-20200413_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "hqy-20200413_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "hqy-20200413.xsd" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "hqy", "nsuri": "http://healthequity.com/20200413", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hqy-20200413.htm", "contextRef": "iaf96966b6ad3414fae8f4b6e6970f2c6_D20200413-20200413", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://healthequity.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hqy-20200413.htm", "contextRef": "iaf96966b6ad3414fae8f4b6e6970f2c6_D20200413-20200413", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthequity.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 hqy-20200413_htm.xml IDEA: XBRL DOCUMENT 0001428336 2020-04-13 2020-04-13 0001428336 false 8-K 2020-04-13 HEALTHEQUITY, INC. DE 001-36568 52-2383166 15 West Scenic Pointe Drive Suite 100 Draper UT 84020 801 727-1000 false false false false Common stock, par value $0.0001 per share HQY NASDAQ false XML 14 R1.htm IDEA: XBRL DOCUMENT v3.20.1
Cover Page
Apr. 13, 2020
Cover [Abstract]  
Document Type 8-K
Document Period End Date Apr. 13, 2020
Entity File Number 001-36568
Entity Registrant Name HEALTHEQUITY, INC.
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 52-2383166
Entity Address, Address Line One 15 West Scenic Pointe Drive
Entity Address, Address Line Two Suite 100
Entity Address, City or Town Draper
Entity Address, State or Province UT
Entity Address, Postal Zip Code 84020
City Area Code 801
Local Phone Number 727-1000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, par value $0.0001 per share
Trading Symbol HQY
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001428336
Amendment Flag false
XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Page Sheet http://healthequity.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports hqy-20200413.htm hqy-20200413.xsd hqy-20200413_cal.xml hqy-20200413_def.xml hqy-20200413_lab.xml hqy-20200413_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true true